IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS
Objective — to evaluate the impact of tocilizumab (TCZ) therapy on progression of joint destruction and rheumatoid arthritis (RA) inflammatory activity in 48 weeks after initiation of treatment. Material and methods. 42 RA patients who received 6 intravenous TCZ infusions at dose 8 mg/kg given once...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Russo |
| Baskı/Yayın Bilgisi: |
IMA PRESS LLC
2012-10-01
|
| Seri Bilgileri: | Научно-практическая ревматология |
| Konular: | |
| Online Erişim: | https://rsp.mediar-press.net/rsp/article/view/1090 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|